Smith Group Asset Management, LLC

SEC CIK: 0001893134
Latest filing: Aug 3, 2026

SEC filings (opens in a new tab)

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Smith Group Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overview All 13F holders of DNLI Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2021

Holdings of DNLI by Smith Group Asset Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−110−100.0%	Sold out	Holders
Q4 2021	110	$5.00K	<0.1%	00.0%	Unchanged	Holders
Q3 2021	110	$6.00K	<0.1%	–	No prior filing	Holders